The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research, population science and patient care. In keeping with our commitment to contemporary topics and scientific advance on a global scale, the Journal has established a section dedicated to the COVID-19 pandemic with an accelerated peer review, decision, and publication of scholarly review papers, observational studies and randomized clinical trials that will inform scientific undertakings and patient management.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular medicine. Published works will also define platforms for translational research, drug development, clinical trials, new drugs and devices, and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular medicine.

The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health, population science, and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors.

Manuscripts submitted must not be under consideration by another journal and should not have been published elsewhere in similar form. All articles will be reviewed by a minimum of two highly qualified referees. All clinical trials being considered for publication will also be reviewed by a statistician. A response will be provided within 2-3 weeks of receipt.

Editor-in-Chief:

Richard C. Becker, M.D.
University of Cincinnati College of Medicine (USA)
Deputy Editor:

Christoph Bode, M.D.
Medizinische Universitaetsklinik Freiburg (Germany)
Associate Editors:
Dominick Angiolillo, MD
University of Florida College of Medicine, Jacksonville, FL (USA)

Section Editors:
Fundamental and Translational Science Translator
Paul Gurbel, MD, Inova Center for Thrombosis Research and Translational Medicine, Lutherville, MD (USA)
Patient Practicums
Brian A. Bergmark, MD, Brigham and Women’s Hospital, Boston, MA (USA)
New Drugs and Devices 
Hareeprasad Vongooru, MD, St. Elizabeth Healthcare, Covington, KY (USA)
Clinical Trials and Methods
Matthew Roe, MD, Duke University, Durham, NC (USA)
Education, Training, Networking and Career Development Series
Matthew Rondina, MD, MS, University of Utah, Salt Lake City, UT (USA)
Fundamental and Translational Science: Research Models and Platforms 
Sakthivel Sadayappan, PhD, MBA, University of Cincinnati, Cincinnati, OH (USA)
National and International Meeting Highlights
Dylan Steen, MD, University of Cincinnati, Cincinnati, OH (USA)
Editorial Board:

Rupert Bauersachs, MD, Darmstadt Clinic, Darmstadt, Germany
Ian Beales, MD, Norfolk and Norwich University Hospital, Norfolk, UK
Gerald Bloomfield, MD, Duke University Medical Center, Durham, NC, USA
Michael Bode, MD, Massachusetts General Hospital, Boston, MA, USA
Mark Chan, MBBS, MHSc, National University Heart Centre, Singapore
Alexandru Costea, MD, University of Cincinnati, Cincinnati, OH, USA
Daniel Duerschmied, MD, University Medical Center Freiburg, Freiburg, Germany
Mark Eckman, MD, MS, University of Cincinnati, Cincinnati, OH, USA
Nicola Fiotti, MD, University of Trieste, Trieste, Italy
David Garcia, MD, University of Washington Medical Center, Seattle, WA, USA
Diana Gorog, MD, PhD, FRCP, Imperial College and ENHT, London, UK
Graeme J. Hankey, MD, University of Western Australia, Crawley, Australia
Larry R. Jackson, MD, Duke University Medical Center, Durham, NC, USA
Stefan James, MD, PhD, Uppsala University, Uppsala, Sweden
Carl (Chip) J. Lavie, MD, John Ochsner Heart and Vascular Institute, New Orleans, LA, USA
Ara Metjian, MD, Duke University Medical Center, Durham, NC, USA
Vance G. Nielsen, MD, University of Arizona, Tucson, Arizona, USA
Michelle O’Donoghue, MD, Brigham and Women’s Hospital, Boston, MA, USA
Jonathan Piccini, MD, Duke University Medical Center, Durham, NC, USA
Thomas Povsic, MD, Duke University Medical Center, Durham, NC, USA
Susan Smyth, MD, PhD, University of Kentucky, College of Medicine, Lexington, KY, USA
Frederick A. Spencer, MD, McMaster University, Hamilton, Ontario, Canada
Josep Rodés-Cabau, MD, Quebec Heart and Lung Institute, Quebec City, Quebec, Canada
Christian Ruff, MD, MPH, Brigham and Women's Hospital, Boston, MA, USA 
John Vavalle, MD, MHS, FACC, UNC School of Medicine, Chapel Hill, NC, USA 
Jiguang Wang, MD, PhD, Shanghai Jiaotong University School of Medicine, Shanghai, China
Jeffrey B. Washam, PharmD, FAHA, BCPS Duke Heart Center, Durham, NC, USA